Posts by: Marisa Wexler MS

Marisa Wexler MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

February 20, 2019

Breast Cancer Treatments Could Be Used for Rare Ovarian Cancer, Study Suggests

News

Medications currently approved to treat some kinds of breast cancer — generally called CDK4/6 inhibitors — could be re-purposed to treat a rare type of ovarian cancer called small cell carcinoma ... Read more

February 11, 2019

Losartan May Improve Ovarian Cancer Treatment, Study Finds

News

Losartan, a medicine used for treating high blood pressure, might improve ovarian cancer treatment by making it easier for chemotherapy drugs to get to tumor cells, a study found. Patients with ... Read more

January 23, 2019

Researchers Use Stem Cells to Produce Cancer-targeting Antibodies

News

In a new study, researchers have used stem cell proteins to create an antibody that can specifically recognize and be taken up by some types of breast and ovarian cancers. ... Read more

January 3, 2019January 3, 2020

Helomics Starts AI-based Tumor Sequencing Aimed at Predicting OC Treatment Responses

News

Helomics, a subsidiary of Predictive Oncology, has begun sequencing tumor samples as part of its collaboration with UPMC Magee Women’s Hospital. The partners aim to use artificial intelligence (AI) to ... Read more

December 17, 2018

Bacterial Toxin-based Test Could Help Detect Ovarian Cancer Early

News

A bacterial toxin-based blood test could help in the early detection of ovarian cancer, and function as a tool for monitoring treatment and disease progression in patients with advanced disease, ... Read more